News

Discovering Breakthroughs in Duchenne Muscular Dystrophy Therapy

Discovering Breakthroughs in Duchenne Muscular Dystrophy Therapy

REGENXBIO Webcast Highlights

REGENXBIO Inc. is preparing an engaging webcast that will focus on the AFFINITY DUCHENNE pivotal program and reveal the very first functional data deriving from the RGX-202 trial. Leading experts will discuss these promising developments, which could dramatically impact the treatment landscape for Duchenne muscular dystrophy.

Featuring Leading Experts

The event will showcase insights from recognized professionals in the field. Among the featured speakers is Aravindhan Veerapandiyan, M.D., who serves as the principal investigator for the AFFINITY DUCHENNE trial, a vital study exploring advanced treatment methodologies for Duchenne muscular dystrophy. Joining him will be Michael Kelly, PhD, the Chief Scientific Officer of CureDuchenne. Together, they will share the latest findings from this noteworthy clinical study.

About the Webcast

This informative session is set to take place on a Monday morning at 8:00 a.m. EST, making it easy for participants to join and catch the latest developments in gene therapy. Attendees will gain firsthand insights into the pivotal program of RGX-202 and learn about interim clinical data. Those interested can access the live webcast on REGENXBIO's website, ensuring a broader outreach for their innovative research and potential breakthroughs in therapy.

Presenting at Key Conferences

In addition to the webcast, the significant findings will be highlighted at esteemed conferences, including the American Society of Gene and Cell Therapy and the Muscular Dystrophy Association's upcoming gathering. These events are excellent opportunities for professionals and researchers to come together and discuss groundbreaking advancements in muscular dystrophy therapies.

About REGENXBIO Inc.

Founded in 2009, REGENXBIO has established itself as a leader in the development of gene therapies. The company’s focus lies in AAV Therapeutics—an innovative class of gene therapy capable of delivering transformative treatments for patients. With ongoing projects targeting neurological and retinal diseases, REGENXBIO aims to bring substantial improvements to the lives of patients suffering from rare genetic disorders.

Among its remarkable projects, RGX-202 stands out as an exploration into treating Duchenne muscular dystrophy. Additionally, the company is advancing ABBV-RGX-314, aimed at treating conditions such as wet age-related macular degeneration in partnership with AbbVie, and RGX-121 for the treatment of MPS II. Thousands of patients have benefitted from REGENXBIO's therapies, showcasing the promise of AAV Therapeutics in altering healthcare paradigms.

Corporate Communications and Investor Relations

For any queries regarding the webcast or for more corporate information, interested parties can get in touch with Dana Cormack from Corporate Communications. Furthermore, George E. MacDougall is available for inquiries on investor relations, ensuring that stakeholders receive timely updates regarding the company's progress and initiatives.

Frequently Asked Questions

What is the purpose of the REGENXBIO webcast?

The webcast focuses on discussing the AFFINITY DUCHENNE pivotal program and presenting the first functional clinical data from the ongoing RGX-202 trial.

Who are the featured speakers at the webcast?

The webcast will feature Aravindhan Veerapandiyan, M.D., and Michael Kelly, PhD, offering insights into their research and findings.

When is the webcast scheduled to take place?

The webcast is scheduled for a Monday at 8:00 a.m. EST.

Where can I access the webcast?

The live webcast will be accessible on REGENXBIO's official website in the Investors section.

What other events will showcase REGENXBIO's findings?

The findings from the RGX-202 trial will also be presented at major conferences such as the American Society of Gene and Cell Therapy.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Sunrate's Bold Move: New Payment Bond with Netstorming

Updated Category News Views 53

Sunrate Joins Forces with Netstorming When two industry powerhouses shake hands, it's wise to sit up and listen. Sunrate, the global whiz in payment solutions, has linked arms with Netstorming, a tech-savvy pioneer in the travel sector. This ironclad partnership was announced at World Travel Market London 2026. Owners of travel businesses should take note: things are...

Continue Reading
Tellus Offers Seamless Security with Passkey Sign-In

Updated Category News Views 65

Tellus Brings a New Era of Convenience Even the most innovative, forward-thinking companies occasionally have to change step to keep up with the relentless march of technology. That's what Tellus App, Inc., a proptech company from Silicon Valley, is doing with its latest announcement to offer passkey sign-ins for its savings app across iOS, Android, and the web. In...

Continue Reading
Mill Creek's Bold Move into Denver's Cherry Creek

Updated Category News Views 60

Taking a Stroll Down Cherry Creek The move by Mill Creek Residential into Cherry Creek North is a bold one, but they aren't exactly newcomers to this high-end neighborhood. They're planting their flag with the Modera Second Avenue, targeting Denver's upscale renters. With a Walk Score of 89, the location is a sweet spot for deep-pocketed folks who want the boutiques and...

Continue Reading
BAIC FOTON Expands With New Trucks in Africa

Updated Category News Views 123

Innovation in African Mobility Amidst the sparse horizons of Port Elizabeth, South Africa, BAIC FOTON is shifting gears in a big way. They've rolled out a duo of heavy-duty trucks—the GALAXUS R5 and C5—and topped it off with the TUNLAND V PHEV plug-in hybrid pickup. On October 29, the Africa Regional Partner Conference buzzed with talk of 'Driving to Great,' signaling...

Continue Reading
LITE, RRC, SGRY: Are Shareholders Getting Shortchanged?

Updated Category News Views 39

What's Really Going On Here? Here's the skinny: Halper Sadeh LLC, that hard-hitting investor rights law firm, is poking their noses into some potential red flags over at a few companies you might have heard of—Lumentum Holdings (NASDAQ:LITE), Range Resources (NYSE:RRC), and Surgery Partners (NASDAQ:SGRY). They're sniffing around transactions that might leave the regular...

Continue Reading
Fluence Energy Faces Stock Woes Amid Legal Challenges

Updated Category News Views 60

A Wild Ride for Fluence Energy Shareholders Damn, if you blinked, you might've missed the plummet of Fluence Energy, Inc. (NASDAQ:FLNC). This kind of nosedive, a brutal 34.63% drop, is the stuff investors fear most. It's like finding a flat tire on the road to profits. But here we are, dissecting the mess that unfolded between November 2025 and September 2026. The meat on...

Continue Reading
Levvy AI: Transforming Hidden Hours into Advisory Gold

Updated Category News Views 16

Unlocking Hidden Potential: Levvy AI on the Scene Picture this: you're running an accounting shop and drowning in an ocean of endless tasks, manual entries, and those cursed follow-ups. That's probably the daily grind, right? Well, it looks like Levvy has decided to break those shackles. This company, based over there in Brooklyn, is rolling out these fancy Levvy AI...

Continue Reading
Speakeasy Dispensary Brings Medical Cannabis to Maysville

Updated Category News Views 74

New Chapter for Maysville: Speakeasy Opens Doors Normally, you'd think of medical cannabis expansions as dry numbers and policies, but with Speakeasy Dispensary making its mark in Maysville, it's not just about business; it's a service to the community. Nestled into 317 W 2nd St, this is more than a simple retail spot. It's about bringing medical options straight to the...

Continue Reading
BAC Faces Class Action as Compliance Issues Loom

Updated Category News Views 18

The air around Bank of America (NYSE: BAC) has turned a shade darker, and if you've been following the script, this was only a matter of time. With Capitol Hill heavies like Senator Elizabeth Warren banging the drum, the squabble over compliance isn't just noise—it's a full-blown siren wailing in the middle of the trading floor. Enforcement and Reaction: A Boiling Pot...

Continue Reading
Connecting NIH Data: Transforming Scientific Discoveries

Updated Category News Views 53

Rethinking How Research Data Drives Discovery When researchers generate truckloads of data, finding patterns that lead to breakthroughs often becomes a game of hide and seek. It's like having a jumbo puzzle with pieces scattered all over the place. Enter the NIH Common Fund Data Ecosystem—a game changer attempting to glue together these pieces across the research...

Continue Reading

Top 5 Most Recently Viewed Articles

Effeect Earns Recognition as Premier PPC Marketing Agency

Updated Category News Views 149

Introduction to Effeect's Achievement Effeect, a notable digital marketing agency, has proudly earned the title of Top PPC Agency from DesignRush, highlighting its exceptional expertise in Pay-Per-Click advertising. This distinction emphasizes Effeect’s proven ability to foster growth for its clients through carefully crafted advertising strategies. What Sets Effeect...

Continue Reading
Celebrating Andrea Mitchell: A Trailblazer in Journalism

Updated Category News Views 419

Andrea Mitchell to Be Honored with Gracies Icon Award The Alliance for Women in Media (AWM) has announced that Andrea Mitchell, the esteemed Chief Foreign Affairs Correspondent for NBC News, will be recognized with the prestigious Gracies Icon Award. This notable accolade will be presented at the 2024 Gracies Leadership Awards, which is set to occur at a significant lunch...

Continue Reading
Celebrating Educators: Eyemart Express Joins Forces with Jennifer Hudson

Updated Category News Views 209

Eyemart Express Honoring Teachers with Significant Donations The national optical retailer helps educators see a brighter future for students through impactful donations. Bringing Recognition to Deserving Educators Eyemart Express is shining a light on educators by collaborating with The Jennifer Hudson Show. This partnership is a tribute to three exceptional teachers...

Continue Reading
BAE Systems Secures $16 Million DARPA Contract for Surveillance

Updated Category News Views 184

BAE Systems Wins $16 Million DARPA Contract for Oversight Program BAE Systems' FAST Labs organization has recently been awarded a significant phase 2 contract worth $16 million by the U.S. Defense Advanced Research Projects Agency (DARPA) for its Oversight program. This initiative primarily focuses on developing an autonomous system capable of maintaining continuous...

Continue Reading
Unveiling Tencent Games' Grand Strategy for Gamescom 2025

Updated Category News Views 275

Tencent Games' Grand Strategy at Gamescom 2025 Tencent Games, a major player in the global gaming landscape, has confirmed its participation in gamescom 2025, which will take place in Cologne, Germany, from August 20 to 24. This event signifies Tencent's largest showcase to date, featuring a broad array of over a dozen exciting titles from its vast portfolio of owned and...

Continue Reading